Bioventus (BVS) Total Debt (2020 - 2026)
Bioventus' (BVS) quarterly Total Debt came in at $272.1 million in Q1 2026, down 14.75% YoY from $319.2 million in Q1 2025, and down 7.44% on a QoQ basis from $294.0 million in Q4 2025.
Bioventus (BVS) Total Debt (2020 - 2026) Analysis & Trends
Bioventus (BVS) has 7 years of Total Debt data on file, last reported at $272.1 million in Q1 2026.
- Quarterly Total Debt fell 14.75% year-over-year to $272.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $272.1 million (down 14.75% YoY) and the FY2025 annual result came in at $294.0 million, down 12.42% from the prior year.
- Total Debt eased to $272.1 million in Q1 2026, from $294.0 million in the prior quarter.
- In the past five years, Total Debt ranged from a high of $445.6 million in Q2 2023 to a low of $272.1 million in Q1 2026.
- A 5-year average of $363.8 million and a median of $374.0 million in 2022 frame the typical range for Total Debt.
- Annual changes were most pronounced in 2022 — Total Debt surged 139.19% — and 2025, when it slipped 18.42%.
- Tracing BVS's Total Debt over 5 years: stood at $418.1 million in 2022, then declined by 5.55% to $394.8 million in 2023, then dropped by 15.0% to $335.6 million in 2024, then fell by 12.42% to $294.0 million in 2025, then slipped by 7.44% to $272.1 million in 2026.
- The last three Total Debt figures came in at $272.1 million (Q1 2026), $294.0 million (Q4 2025), and $322.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.12 Bn | 193.52 Bn | 7.27 Bn | 32.61 Bn |
| 2 | Stryker | 128.79 Bn | 125.32 Bn | 4.50 Bn | 14.94 Bn |
| 3 | Medtronic | 119.30 Bn | 110.08 Bn | 6.41 Bn | 27.96 Bn |
| 4 | Boston Scientific | 73.50 Bn | 72.96 Bn | 3.85 Bn | 12.62 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.86 Bn | 1.35 Bn | 598.70 Mn |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.05 Bn | 31.94 Bn | 2.18 Bn | 10.10 Bn |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn | 8.68 Bn |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | 1.89 Bn |
| 10 | Bioventus | 970.53 Mn | 941.07 Mn | 105.67 Mn | 248.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 248.45 Mn |
| Mar 28, 2026 | 272.08 Mn |
| Dec 31, 2025 | 293.95 Mn |
| Sep 27, 2025 | 322.58 Mn |
| Jun 28, 2025 | 297.88 Mn |
| Mar 29, 2025 | 319.17 Mn |
| Dec 31, 2024 | 335.63 Mn |
| Sep 28, 2024 | 383.59 Mn |
| Jun 29, 2024 | 363.46 Mn |
| Mar 30, 2024 | 391.24 Mn |
| Dec 31, 2023 | 394.85 Mn |
| Sep 30, 2023 | 394.62 Mn |
| Jul 1, 2023 | 385.89 Mn |
| Apr 1, 2023 | 445.59 Mn |
| Dec 31, 2022 | 418.07 Mn |
| Oct 1, 2022 | 424.40 Mn |
| Jul 2, 2022 | 373.98 Mn |
| Apr 2, 2022 | 368.33 Mn |
| Dec 31, 2021 | 357.68 Mn |
| Oct 2, 2021 | 177.44 Mn |